The effects of nateglinide and acarbose on the post-prandial glucose control in type 2 diabetic patients
Phase of Trial: Phase IV
Latest Information Update: 21 Mar 2008
At a glance
- Drugs Acarbose; Nateglinide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Mar 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 26 Mar 2007 New trial record.